Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Seppälä P[au]:

Search results

Items: 1 to 50 of 60

1.

A two-wave quasi-experimental intervention study of a participatory visual art intervention: unexpected effects on job resources and work engagement.

Seppälä P, Ansio H, Houni P, Hakanen JJ.

Arts Health. 2018 Sep 17:1-15. doi: 10.1080/17533015.2018.1517370. [Epub ahead of print]

PMID:
31038432
2.

High Job Demands, Still Engaged and Not Burned Out? The Role of Job Crafting.

Hakanen JJ, Seppälä P, Peeters MCW.

Int J Behav Med. 2017 Aug;24(4):619-627. doi: 10.1007/s12529-017-9638-3.

PMID:
28130738
3.
4.

Synthesis, crystal structures and magnetic properties of bis(μ-dialkoxo)-bridged linear trinuclear copper(II) complexes with aminoalcohol ligands: a theoretical/experimental magneto-structural study.

Seppälä P, Colacio E, Mota AJ, Sillanpää R.

Dalton Trans. 2012 Mar 7;41(9):2648-58. doi: 10.1039/c2dt11628f. Epub 2012 Jan 11.

PMID:
22234645
5.

Touching the upper limit for ferromagnetic interactions in hetero-bridged dinuclear [Cu2(II)] complexes using a novel N5-dinucleating ligand bearing an endogenous monoatomic amido(R-NH(-))-bridging group.

Colacio E, Perea-Buceta JE, Mota AJ, Brechin EK, Prescimone A, Hänninen M, Seppälä P, Sillanpää R.

Chem Commun (Camb). 2012 Jan 21;48(6):805-7. doi: 10.1039/c1cc16590a. Epub 2011 Dec 5.

PMID:
22138975
6.

A combined experimental and theoretical charge density study of the chemical bonding and magnetism in 3-amino-propanolato Cu(II) complexes containing weakly coordinated anions.

Farrugia LJ, Middlemiss DS, Sillanpää R, Seppälä P.

J Phys Chem A. 2008 Sep 25;112(38):9050-67. doi: 10.1021/jp804865j. Epub 2008 Aug 29.

PMID:
18759408
7.

Effect of obesity on the response to insulin therapy in noninsulin-dependent diabetes mellitus.

Yki-Järvinen H, Ryysy L, Kauppila M, Kujansuu E, Lahti J, Marjanen T, Niskanen L, Rajala S, Salo S, Seppälä P, Tulokas T, Viikari J, Taskinen MR.

J Clin Endocrinol Metab. 1997 Dec;82(12):4037-43.

PMID:
9398709
8.

Effect of insulin treatment on serum lipoprotein(a) in non-insulin-dependent diabetes.

Kuusi T, Yki-Järvinen H, Kauppinen-Mäkelin R, Jauhiainen M, Ehnholm C, Kauppila M, Seppälä P, Viikari J, Kujansuu E, Rajala S, et al.

Eur J Clin Invest. 1995 Mar;25(3):194-200.

PMID:
7781667
9.

Comparison of insulin regimens in patients with non-insulin-dependent diabetes mellitus.

Yki-Järvinen H, Kauppila M, Kujansuu E, Lahti J, Marjanen T, Niskanen L, Rajala S, Ryysy L, Salo S, Seppälä P, et al.

N Engl J Med. 1992 Nov 12;327(20):1426-33.

10.

Cardiac systolic time intervals and thyroid hormone levels during treatment of hypothyroidism.

Nuutila P, Irjala K, Saraste M, Seppälä P, Viikari J.

Scand J Clin Lab Invest. 1992 Oct;52(6):467-77.

PMID:
1411259
11.

Hyperthyroidism with normal values for total thyroxin in serum.

Nuutila P, Irjala K, Kaihola HL, Seppälä P, Viikari J.

Clin Chem. 1991 Jun;37(6):1120. No abstract available.

PMID:
2049831
12.

[Diabetic individual as a surgical patient].

Salo MS, Seppälä P, Viikari J.

Duodecim. 1991;107(6):389-98. Review. Finnish. No abstract available.

PMID:
1364885
13.

Two new two-step immunoassays for free thyroxin evaluated: solid-phase radioimmunoassay and time-resolved fluoroimmunoassay.

Nuutila P, Koskinen P, Irjala K, Linko L, Kaihola HL, Eskola JU, Erkkola R, Seppälä P, Viikari J.

Clin Chem. 1990 Jul;36(7):1355-60. Erratum in: Clin Chem. 1993 Jul;39(7):1555-6.

14.

Endocrine abnormalities in patients with adrenal tumours incidentally discovered on computed tomography.

Virkkala A, Välimäki M, Pelkonen R, Huikuri K, Kahri A, Kivisaari L, Korhonen T, Salmi J, Seppälä P.

Acta Endocrinol (Copenh). 1989 Jul;121(1):67-72.

PMID:
2545064
15.

[Protracted vitamin D poisoning].

Mäki M, Viikari J, Seppälä P, Haataja M.

Duodecim. 1988;104(13):997-1000. Finnish. No abstract available.

PMID:
3168814
16.

[Focal nodules in necrotizing myopathies of diabetic patients].

Nuutila P, Röyttä M, Alanen A, Seppälä P.

Duodecim. 1987;103(17):1046-52. Review. Finnish. No abstract available.

PMID:
3322791
17.

Plasma and urinary C-peptide in the classification of adult diabetics.

Koskinen P, Viikari J, Irjala K, Kaihola HL, Seppälä P.

Scand J Clin Lab Invest. 1986 Nov;46(7):655-63.

PMID:
3538365
18.

Unusual association of hyperkalemia and hypertension.

Soppi E, Viikari J, Seppälä P, Lehtonen A, Saarinen R, Miilunpalo S.

Hypertension. 1986 Feb;8(2):174-7.

PMID:
2417952
19.

C-peptide determination in the choice of treatment in diabetes mellitus.

Koskinen P, Viikari J, Irjala K, Kaihola HL, Seppälä P.

Scand J Clin Lab Invest. 1985 Nov;45(7):589-97.

PMID:
3906851
20.

[Celiac disease and malignant histiocytosis of the intestines].

Aho H, Soppi E, Seppälä P.

Duodecim. 1985;101(18):1794-800. Finnish. No abstract available.

PMID:
4064959
21.

[Drug-induced hepatitis in a diabetic patient].

Kantola I, Viikari J, Leino R, Seppälä P.

Duodecim. 1985;101(6):587-90. Finnish. No abstract available.

PMID:
3987570
22.

Virilization during pregnancy due to bilateral hyperthecosis. A case report.

Erkkola R, Seppälä P, Klemi PJ.

Horm Res. 1985;21(2):83-7.

PMID:
3979948
23.

Effect of guar gum on glipizide absorption in man.

Huupponen R, Karhuvaara S, Seppälä P.

Eur J Clin Pharmacol. 1985;28(6):717-9.

PMID:
2998803
24.

Remissions in newly diagnosed type 1 (insulin-dependent) diabetes: influence of interferon as an adjunct to insulin therapy.

Koivisto VA, Aro A, Cantell K, Haataja M, Huttunen J, Karonen SL, Mustajoki P, Pelkonen R, Seppälä P.

Diabetologia. 1984 Aug;27(2):193-7.

PMID:
6386581
25.

[Traffic and chronic illness].

Laaksonen H, Seppälä P.

Duodecim. 1984;100(19):1209-19. Finnish. No abstract available.

PMID:
6510282
26.

[Basal C-peptide determination or glucagon stimulation test in the choice of treatment of diabetes mellitus?].

Koskinen P, Viikari J, Irjala K, Kaihola HL, Seppälä P.

Duodecim. 1984;100(6):336-41. Finnish. No abstract available.

PMID:
6370656
27.

Effect of guar gum, a fibre preparation, on digoxin and penicillin absorption in man.

Huupponen R, Seppälä P, Iisalo E.

Eur J Clin Pharmacol. 1984;26(2):279-81.

PMID:
6327318
28.

Glipizide pharmacokinetics and response in diabetics.

Huupponen R, Seppälä P, Iisalo E.

Int J Clin Pharmacol Ther Toxicol. 1982 Sep;20(9):417-22.

PMID:
6754633
30.

Connective tissue components in normal and atherosclerotic human coronary arteries.

Tammi M, Seppälä PO, Lehtonen A, Möttönen M.

Atherosclerosis. 1978 Feb;29(2):191-4.

PMID:
646848
31.

Growth hormone and cortisol secretion after oral and intravenous administration of methyldopa.

Syvälahti E, Seppälä PO, Iisalo E.

Acta Pharmacol Toxicol (Copenh). 1975 Sep;37(3):257-64. No abstract available.

PMID:
1103571
32.
33.

Visual fatigue in reading microfilms.

Seppäla P.

Agressologie. 1975;16(3):147-50. No abstract available.

PMID:
1211540
34.

Synovial fluid analysis and its clinical significance.

Hüttl S, Hedberg H, Seppälä P.

Scand J Rheumatol Suppl. 1975;12:148-9. No abstract available.

PMID:
1084562
35.

[The biochemistry of articular cartilage in osteoarthritis].

Seppälä PO, Näntö V.

Duodecim. 1974;90(16):1107-15. Finnish. No abstract available.

PMID:
4277945
36.

Biochemical analysis of the intestinal wall in a case of regional enteritis (Crohn's disease).

Seppälä PO, Viljanto J, Lehtonen A.

Acta Chir Scand. 1973;139(1):79-83. No abstract available.

PMID:
4266406
37.

Chondroitin sulphate in the normal and rheumatoid synovial fluid.

Seppälä PO, Kärkkäinen J, Lehtonen A, Mäkisara P.

Clin Chim Acta. 1972 Feb;36(2):549-53. No abstract available.

PMID:
5008811
38.

Chemical changes underlying Dupuytren's contracture.

Viljanto J, Seppälä PO, Lehtonen A.

Ann Rheum Dis. 1971 Jul;30(4):423-7. No abstract available.

39.

[Management of diabetic patients undergoing surgery].

Seppälä PO.

Duodecim. 1971;87(2):164-8. Finnish. No abstract available.

PMID:
5573219
40.
41.

Physical fitness of university students.

Vuori IM, Heikkinen E, Seppälä PO.

J Sports Med Phys Fitness. 1969 Mar;9(1):40-8. No abstract available.

PMID:
5789288
42.

[Viscoelastic properties of synovial fluid].

Seppälä PO.

Duodecim. 1969;85(18):1137-43. Finnish. No abstract available.

PMID:
5371394
43.

The presence of chondroitin sulphate in the synovial fluid in rheumatoid arthritis.

Seppälä P, Lehtonen A, Kärkkäinen J, Näntö V.

Clin Chim Acta. 1967 Apr;16(1):115-9. No abstract available.

PMID:
4227009
44.

Oral tyrosine tolerance test in rheumatoid arthritis.

Kalliomäki JL, Lehtonen A, Seppälä P.

Ann Rheum Dis. 1966 Sep;25(5):469-71. No abstract available.

45.

Physicochemical properties of synovial fluid with reference to rheumatoid disease and the effect of hydrocortisone treatment.

Kulonen E, Mäkisara P, Seppälä P, Näntö V.

Fed Proc. 1966 May-Jun;25(3):1141-3. No abstract available.

PMID:
5941001
46.

Latex slide test in thyroid diseases.

Oka M, Seppälä P, Mikkonen L.

Acta Med Scand. 1966 Feb;179(2):253-5. No abstract available.

PMID:
5908979
47.

[Arthromyodysplasia congenita (Guérin-Stern)].

Väänänen I, Seppälä P.

Duodecim. 1966;82(1):26-8. Finnish. No abstract available.

PMID:
5909257
48.
49.

Effect of acidification on the electrophoretic pattern of anacid gastric juice.

BRUMMER P, SEPPALA P.

Am J Dig Dis. 1963 Jun;8:473-7. No abstract available.

PMID:
14016246
50.

Inhibition of cholesterol biosynthesis by triparanol in rheumatoid arthritis.

KALLIOMAKI JL, SAARIMAA HA, SEPPALA PO.

Ann Rheum Dis. 1963 Mar;22:110-2. No abstract available.

Supplemental Content

Loading ...
Support Center